Lam Research Corporation $LRCX Shares Acquired by Migdal Insurance & Financial Holdings Ltd.

Migdal Insurance & Financial Holdings Ltd. increased its stake in Lam Research Corporation (NASDAQ:LRCX) by 6,769.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 210,534 shares of the semiconductor company’s stock after acquiring an additional 207,469 shares during the quarter. Migdal Insurance & Financial Holdings Ltd.’s holdings in Lam Research were worth $36,039,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of LRCX. Brighton Jones LLC grew its holdings in shares of Lam Research by 1,032.4% in the 4th quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock worth $1,025,000 after acquiring an additional 12,936 shares during the last quarter. Caxton Associates LLP purchased a new position in shares of Lam Research during the first quarter valued at $239,000. Gabelli Funds LLC purchased a new position in shares of Lam Research during the second quarter valued at $253,000. NewEdge Advisors LLC grew its holdings in shares of Lam Research by 2.7% during the second quarter. NewEdge Advisors LLC now owns 100,528 shares of the semiconductor company’s stock valued at $9,785,000 after buying an additional 2,661 shares in the last quarter. Finally, Osterweis Capital Management Inc. grew its holdings in shares of Lam Research by 5,206.7% during the second quarter. Osterweis Capital Management Inc. now owns 796 shares of the semiconductor company’s stock valued at $77,000 after buying an additional 781 shares in the last quarter. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Lam Research

In other Lam Research news, insider Ava Harter sold 4,000 shares of the business’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $232.50, for a total value of $930,000.00. Following the transaction, the insider owned 54,705 shares in the company, valued at $12,718,912.50. The trade was a 6.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Eric Brandt sold 35,000 shares of the business’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $225.60, for a total value of $7,896,000.00. Following the completion of the transaction, the director owned 253,705 shares in the company, valued at $57,235,848. This trade represents a 12.12% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 130,886 shares of company stock worth $29,658,802 over the last 90 days. 0.31% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on LRCX shares. Weiss Ratings reiterated a “buy (b-)” rating on shares of Lam Research in a report on Friday, April 10th. Mizuho set a $265.00 price target on Lam Research in a report on Wednesday, January 28th. Erste Group Bank downgraded Lam Research from a “buy” rating to a “hold” rating in a report on Thursday, April 2nd. Evercore set a $275.00 price target on Lam Research in a report on Thursday, January 29th. Finally, KeyCorp reiterated a “sector weight” rating on shares of Lam Research in a report on Thursday, January 29th. Twenty-seven research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $247.26.

Lam Research Stock Performance

Shares of NASDAQ LRCX opened at $258.37 on Wednesday. The business’s 50-day moving average price is $233.19 and its two-hundred day moving average price is $196.10. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.26 and a quick ratio of 1.61. Lam Research Corporation has a one year low of $62.56 and a one year high of $273.50. The company has a market capitalization of $322.64 billion, a P/E ratio of 52.94, a price-to-earnings-growth ratio of 2.80 and a beta of 1.78.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 EPS for the quarter, beating analysts’ consensus estimates of $1.17 by $0.10. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The firm had revenue of $5.34 billion for the quarter, compared to the consensus estimate of $5.23 billion. During the same quarter in the previous year, the company posted $0.91 earnings per share. The business’s quarterly revenue was up 22.1% compared to the same quarter last year. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Analysts anticipate that Lam Research Corporation will post 5.3 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 8th. Shareholders of record on Wednesday, March 4th were paid a $0.26 dividend. The ex-dividend date was Wednesday, March 4th. This represents a $1.04 dividend on an annualized basis and a yield of 0.4%. Lam Research’s payout ratio is 21.31%.

Lam Research Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.